NCT03103022View on ClinicalTrials.gov

Combination of Acetaminophen and Ibuprofen in the Management of Patent Ductus Arteriosus

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 12, 2017

Primary Completion Date

April 30, 2019

Study Completion Date

April 30, 2019

Conditions
Patent Ductus ArteriosusNeonate
Interventions
DRUG

Acetaminophen

Oral acetaminophen \[160 mg/5ml concentration\] will be administered every 6 hours with dose of 15 mg/kg/dose for a total of twelve doses

DRUG

ibuprofen

Oral ibuprofen \[100 mg/5 ml\] at 10 mg/kg/dose on first day followed by 5 mg/kg/dose at 24 and 48 hours for a total of three doses

Trial Locations (2)

32207

Wolfson Children's Hospital, Jacksonville

32209

University of Florida, Jacksonville

All Listed Sponsors
lead

University of Florida

OTHER

NCT03103022 - Combination of Acetaminophen and Ibuprofen in the Management of Patent Ductus Arteriosus | Biotech Hunter | Biotech Hunter